Lucido Louis C.'s Form 4 filing
BioCorRx Inc. (BICX) · filed Aug 31, 2022
- Accession no.
- 0001477932-22-006572
- Filed
- Aug 31, 2022
- Trade date
- Aug 29-31, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market purchases total $8.18K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lucido Louis C.CIK 0001539788 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 29, 2022 | Common Stock, par value $0.001 | PPurchaseAcquired | +1,000 | $2.12 | +$2,120 | 77,507 | Direct | |
| Aug 29, 2022 | Common Stock, par value $0.001 | PPurchaseAcquired | +2,268 | $2.10 | +$4,762.8 | 79,775 | Direct | |
| Aug 31, 2022 | Common Stock, par value $0.001 | PPurchaseAcquired | +610 | $2.12 | +$1,293.2 | 80,385 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.